Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

NCT00053391 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: recombinant CD40-ligand
BIOLOGICAL: therapeutic autologous dendritic cells

Sponsor

University Hospital Erlangen